15th Congress of the European Association for Clinical Pharmacology and Therapeutics, EACPT
European Journal of Clinical Pharmacology
; 78, 2022.
Article
in English
| EMBASE | ID: covidwho-1955687
ABSTRACT
The proceedings contain 294 papers. The topics discussed include impact of the genotype and phenotype of CYP3A and P-GP on the apixaban and rivaroxaban blood concentrations in real-world setting;direct oral anticoagulant-related bleeding in atrial fibrillation patients alters DNA methylation of NOS3 and KDR genes;impact of obesity on dexamethasone pharmacokinetic in COVID-19 hospitalized patients an observational exploratory study;intestinal permeability in transplant patients are systemic short-chain fatty acids an early biomarker?;immunogenicity 5-months after homologous or heterologous booster vaccination in health care workers primed with Ad26.COV2.S;geographic variation in top-10 prescribed medication and potentially inappropriate prescription in Portugal an ecological study of 2.2 million older adults;quantitative proteomics of hepatic drug-metabolizing enzymes and transporters in patients with colorectal cancer liver metastasis;pharmacological characterization of a novel lipid-rich breast cancer patient-derived xenograft;and multiple sclerosis drugs and dental and gingival disorders an observational retrospective study and disproportionality analysis in the world pharmacovigilance database.
ad26.cov2.s vaccine; anticoagulant agent; apixaban; biological marker; cytochrome P450 3A; dexamethasone; drug metabolizing enzyme; endogenous compound; lipid; rivaroxaban; short chain fatty acid; vasculotropin receptor 2; aged; atrial fibrillation; bleeding; blood level; breast cancer; cancer patient; clinical pharmacology; colorectal cancer; conference review; controlled study; coronavirus disease 2019; DNA methylation; drug therapy; drug toxicity; exploratory research; female; genetic marker; genotype; gingiva disease; health care personnel; hospital patient; human; human tissue; immunogenicity; liver metastasis; multiple sclerosis; obesity; pharmacokinetics; pharmacovigilance; phenotype; Portugal; potentially inappropriate medication; proteomics; quantitative analysis; retrospective study; revaccination; surgery; tooth disease; tumor xenograft; xenograft
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
European Journal of Clinical Pharmacology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS